HomeIMVT • NASDAQ
add
Immunovant Inc
Nakaraang pagsara
$23.63
Sakop ng araw
$23.08 - $23.66
Sakop ng taon
$23.08 - $43.92
Market cap
3.45B USD
Average na Volume
885.91K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
(USD) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 115.74M | 87.29% |
Net na kita | -109.12M | -86.01% |
Net profit margin | — | — |
Kita sa bawat share | -0.74 | -64.44% |
EBITDA | -115.65M | -87.31% |
Aktuwal na % ng binabayarang buwis | -0.07% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(USD) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 472.94M | 75.21% |
Kabuuang asset | 515.71M | 76.57% |
Kabuuang sagutin | 66.65M | 65.56% |
Kabuuang equity | 449.05M | — |
Natitirang share | 146.78M | — |
Presyo para makapag-book | 7.72 | — |
Return on assets | -52.35% | — |
Return on capital | -58.23% | — |
Cash Flow
Net change in cash
(USD) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Net na kita | -109.12M | -86.01% |
Cash mula sa mga operasyon | -88.65M | -47.60% |
Cash mula sa pag-invest | -196.00K | -476.47% |
Cash mula sa financing | 730.00K | 393.24% |
Net change in cash | -87.06M | -45.03% |
Malayang cash flow | -43.49M | -8.49% |
Tungkol
Itinatag
2018
Website
Mga Empleyado
207